KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Gross Profit: 2014-2024

Historic Gross Profit for Aurinia Pharmaceuticals (AUPH) over the last 10 years, with Dec 2024 value amounting to $206.9 million.

  • Aurinia Pharmaceuticals' Gross Profit rose 5.76% to $65.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $236.4 million, marking a year-over-year increase of 22.95%. This contributed to the annual value of $206.9 million for FY2024, which is 28.21% up from last year.
  • According to the latest figures from FY2024, Aurinia Pharmaceuticals' Gross Profit is $206.9 million, which was up 28.21% from $161.4 million recorded in FY2023.
  • In the past 5 years, Aurinia Pharmaceuticals' Gross Profit ranged from a high of $206.9 million in FY2024 and a low of $44.5 million during FY2021.
  • In the last 3 years, Aurinia Pharmaceuticals' Gross Profit had a median value of $161.4 million in 2023 and averaged $165.5 million.
  • Its Gross Profit has fluctuated over the past 5 years, first spiked by 15,660.38% in 2020, then dropped by 11.18% in 2021.
  • Over the past 5 years, Aurinia Pharmaceuticals' Gross Profit (Yearly) stood at $50.1 million in 2020, then declined by 11.18% to $44.5 million in 2021, then soared by 188.37% to $128.4 million in 2022, then increased by 25.71% to $161.4 million in 2023, then rose by 28.21% to $206.9 million in 2024.